Table 4.
Author | Year | Type of animal/cells | Weight of animal/Age | Type of RA | Dose of RA | Effect |
---|---|---|---|---|---|---|
Wagner et al. | 2000 | Wistar rats | 180–200 g | ATRA | 10 mg/kg per day | + |
Morath et al. | 2001 | Wistar rats | 180–200 g | ATRA | 10 mg/kg per day | + |
Lehrke et al. | 2002 | Wistar rats | 180–200 g | Ro-257386 | 80 mg/kg per day | + |
Oseto et al. | 2003 | Wistar rats | Twelve-week-old | ATRA | 30 mg/kg per day | + |
Schaier et al. | 2004 | Wistar rats | 145–150 g | AGN 195183 or AGN 194204 | 4 mg/kg, 20 mg/kg per day AGN 195183; 0.4 mg/kg,, 2 mg/kg per day AGN 194204 | + |
Adams et al. | 2005 | Rats | 200–220 g | 13-cis-RA | 2 mg/kg per day | + |
Macrophages, Fibroblasts | – | 13-cis-RA | 10 μM | + | ||
Wen et al. | 2005 | Glomerular mesangial cells | – | 9-cis-RA | 0.01–1 μM | + |
He et al. | 2007 | Mice | – | ATRA | NA | + |
Podocytes | – | ATRA or 9-cis-RA | 0.1–10 μM | + | ||
Iyoda et al. | 2007 | Mice | – | ATRA | 20 mg/kg per day | − |
Xu et al. | 2010 | C57BL/6J × CBA F1 mice | One-week-old | ATRA | 6–10.7 mg/kg per day; 12.7–18.8 mg/kg per day, 20.1–27.4 mg/kg per day | + |
Liu et al. | 2011 | Sprague-Dawley rats | 250–330 g | ATRA | 5 mg/kg per day, 10mg/kg per day | + |
Kishimoto et al. | 2011 | C57BL/B6 mice | 25–30 g (Eight-week-old) | ATRA | 20 mg/kg | + |
Zhong et al. | 2012 | Mice | Four-week-old | Am580 | 0.3 mg/kg per day | + |
Mallipattu et al. | 2012 | Podocytes | – | ATRA | 1 μM | + |
Moulder et al. | 2002 | Rats | – | ATRA | 15 mg/kg per day | + |
Zhou et al. | 2011, 2012 | Wistar rats | 180–200 g | ATRA | 15 mg/kg per day | + |
Note: RA = retinoic acid; ATRA = all-trans retinoic acid; NA = relative data were not available in original paper. Effect +: RA plays a protective role against kidney fibrosis/extracellular matrix accumulation; Effect −: RA plays a negative role in kidney fibrosis/induces the accumulation of extracellular matrix.